This page is currently under construction
Our team are currently working on this page, this content will be back online very soon. Please check back at a later date.
The eye in health and disease: Pathophysiology and treatment of DMO and RVO
Investigate the eye in health and disease – the normal structure and function of the eye, and how this changes as a result of retinal diseases. You will explore the key cells and cytokines involved in the pathophysiology of diabetic macular oedema and retinal vein occlusion, and consider inflammation as a key target for treatment.
No. of CPD hours: 1
Optimising services for the treatment of DMO and RVO
Review the current challenges in ophthalmology services and consider how certain challenges may be overcome on an individual level and an MDT level to improve services and patient outcomes. Additionally, explore how upskilling nurses and other AHPs can positively impact those challenges.
No. of CPD hours: 1
The power of retinal imaging: Predicting response and improving patient outcomes
Examine the different types of imaging available in ophthalmology services to measure visual impairment with confidence, and review prognostic and predictive imaging biomarkers which may guide treatment decisions.
No. of CPD hours: 1
No. of CPD hours: 1
The eye in health and disease: Pathophysiology and treatment of DMO and RVO
Investigate the eye in health and disease – the normal structure and function of the eye, and how this changes as a result of retinal diseases. You will explore the key cells and cytokines involved in the pathophysiology of diabetic macular oedema and retinal vein occlusion, and consider inflammation as a key target for treatment.
No. of CPD hours: 1
Optimising services for the treatment of DMO and RVO
Review the current challenges in ophthalmology services and consider how certain challenges may be overcome on an individual level and an MDT level to improve services and patient outcomes. Additionally, explore how upskilling nurses and other AHPs can positively impact those challenges.
No. of CPD hours: 1
The power of retinal imaging: Predicting response and improving patient outcomes
Examine the different types of imaging available in ophthalmology services to measure visual impairment with confidence, and review prognostic and predictive imaging biomarkers which may guide treatment decisions.
1. OZURDEX®. Summary of Product Characteristics; 2. Garcia-Layana A, et al. Ophthalmologica. 2018;240:61–72.; 3. Wang K, et al. Biol Pharm Bull. 2008;31:1541–6; 4. Rezar-Dreindl S, et al. Acta Ophthalmol. 2017;95:e119–27; 5. Edelman JL, et al. Exp Eye Res. 2005;80:249–58; 6. Tamura H, et al. Invest Ophthalmolo Vis Sci. 2005;46(4):1440–4; 7. Nehme A and Edelman J. Invest Ophthalmol Vis Sci. 2008;49:2030–8.
OZURDEX® PRESCRIBING INFORMATION
By clicking the link above you will leave the AbbVie Pro website and be taken to the eMC PI portal website.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.
Adverse events should also be reported to AbbVie on GBPV@abbvie.com
Date of preparation: December 2024 I UK-OZU-240537
